CareTech gobbling up Selborne Care for £17m

Josh White WebFG News | 19 Jun, 2017 10:02 | | |

cash money sterling pound

CareTech Holding

424.09

08:20 12/12/17
0.20%
0.84
  • 7,592.36
  • -0.20%-15.09
  • Max: 7,622.77
  • Min: 7,589.32
  • Volume: 0
  • MM 200 : n/a
08:30 12/12/17
  • 1,015.55
  • -0.16%-1.63
  • Max: 1,018.28
  • Min: 1,015.55
  • Volume: 0
  • MM 200 : n/a
08:30 12/12/17
  • 5,211.54
  • -0.27%-14.11
  • Max: 5,229.91
  • Min: 5,211.54
  • Volume: 0
  • MM 200 : n/a
08:30 12/12/17

Specialist social care services provider CareTech Holdings announced on Monday that it had agreed to acquire the entire issued share capital of Selborne Care for a total consideration of £16.9m in cash.

The AIM-traded firm described Selborne as a “high quality provider” of specialist residential care, supported living and day care services for adults with learning disabilities and challenging behaviours.

Selborne is based in Droitwich in Worcestershire, and operates across the Midlands and the South West.

It has 57 residential beds in eight freehold sites, with supported living services provided to 30 service users, and “innovative” outreach and day services also offered.

Selborne was founded in 2006 by its directors John McAllister, Michael Stratford, Simon Bishop and Peter Mooney, who all had “extensive” healthcare experience, though would not remain with the business post-completion, the CareTech board said.

The company had delivered year-on-year growth since it was founded.

In the year to 31 December, Selborne reported revenues of £13.3m and EBITDA of £2.4m.

Its net assets on a debt-free, cash-free basis at 31 August 2016 were £13.4m, and the acquisition included freehold properties carried in Selborne's balance sheet valued at £12.4m.

The acquisition, which was expected to be immediately earnings enhancing, was in line with CareTech's strategy of geographic expansion according to the board, and reportedly strengthened its presence and service offering in the Midlands and South West.

It would be financed from existing cash resources.

“We have enjoyed developing Selborne since its creation in 2006 and would like to thank our staff for their support and dedication over this time whose contribution has helped Selborne become the quality operation it is today,” said Selborne chief executive Mike Stratford.

“We are delighted to be handing over to CareTech who we believe share our commitment to customer focused, quality care and support services.'”

Farouq Sheikh, CareTech's executive chairman, said the firm was “delighted” to announce the acquisition of Selborne.

“The acquisition is immediately earnings enhancing.

“In line with our growth strategy, it extends our geographical reach and service offering to local authorities,” Sheikh explained.

“We continue to evaluate other acquisition opportunities to further consolidate our fragmented marketplace.”

More news

08:19 Balfour Beatty's confidence increases on margins, debts

Balfour Beatty is "increasingly confident" of improving margins this year as it continues to win new business on better terms.

07:50 Aggreko confirms timeline for Drewett as new CFO

Aggreko gave a timeline to the appointment of its new chief financial officer on Tuesday, confirming that Heath Drewett would take up the role on 3 January.

07:44 Glencore shareholders to receive upbeat investor update

Glencore shareholders are set to be told of the company’s position as the “leading producer” of tier 1 commodities - that is, copper, cobalt, nickel, zinc and thermal coal - during an investor update set down for Tuesday afternoon.

07:42 Westfield shopping centres to be bought by France's Unibail-Rodamco

Shopping centre owner Westfield has accepted a takeover offer from European rival Unibail-Rodamco, a week after the pair's UK rivals agreed a similar merger.

07:41 London pre-open: Stocks to open higher ahead of inflation data

London stocks were set for a positive open on Tuesday following an upbeat session in the US, as investors eye the release of key UK inflation data.

07:33 GlaxoSmithKline upbeat on 'promising' new data from DREAMM-1 study

GlaxoSmithKline has presented promising new data from the dose expansion phase of the DREAMM-1 study of GSK2857916, an investigational anti-B-cell maturation antigen (BCMA) antibody-drug conjugate.

07:28 Hurricane clean-up boosts Ashtead at half-year, Indivior schizophrenia treatment accepted for FDA review

London open

07:20 Indivior's schizophrenia drug application accepted by US FDA

A one-monthly schizophrenia treatment developed by heroin-addiction specialist Indivior has been accepted for review by the US drug regulator.

07:07 Tuesday newspaper round-up: Trump tax warning, oil pipeline, Comcast, wages

Philip Hammond has joined other EU treasury ministers in warning President Trump about tax plans that they say would breach international agreements and hammer the City of London. In a letter they express “significant concerns” that the Trump administration’s tax plans would have a “major distortive impact on international trade”. - The Times

11 Dec US close: Markets continue run further into record territory

Markets in the US pushed further into record territory on Monday, as investors eyed a rate announcement from the Federal Reserve later in the week.